<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a patient with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) occurring 5 years after successful treatment of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) with antilymphocyte globulin (ALG) </plain></SENT>
<SENT sid="1" pm="."><plain>Four years after ALG, SAA had relapsed </plain></SENT>
<SENT sid="2" pm="."><plain>A second remission of SAA was achieved, but was followed by transformation of the <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> into overt <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>After 2 courses of high-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> and <z:chebi fb="0" ids="4911">VP-16</z:chebi> complete remission occurred </plain></SENT>
<SENT sid="4" pm="."><plain>This case shows that chemotherapy of secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> after SAA is feasible, and that ex-<z:e sem="disease" ids="C1368107" disease_type="Disease or Syndrome" abbrv="">aplastic bone marrow</z:e> is capable of complete recovery from chemotherapy-induced <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Morphological anomalies of bone marrow noticed early during remission of SAA might predict a late transformation in <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>